Skip to main content
. 2019 May 24;10(5):201–212. doi: 10.5306/wjco.v10.i5.201

Table 4.

Safety profile and side effects (grade 3 or 4) n (%)

Toxicities Adjuvant group, n = 25 (100) Neoadjuvant group, n = 13 (100)
Abdominal pain/pelvic pain 16 (64) 5 (38.5)
Nausea/vomiting 9 (36) 4 (30.8)
Fatigue 2 (8) 2 (15.4)
Renal insufficiency 0 (0) 3 (23.1)
Dehydration/hypotension 4 (16) 2 (15.4)
Catheter malfunction/infection 1 (4) 0 (0)
Anemia 3 (12) 1 (7.7)
Thrombocytopenia 1 (4) 0 (0)
Neutropenia 5 (20) 1 (7.7)
Hypokalemia 1 (4) 4 (30.8)
Hypomagnesemia 3 (12) 2 (15.4)